WASHINGTON, D.C. 20549


                                    FORM 8-K


                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934

                Date of Report (Date of Earliest Event Reported):
                                October 18, 2005

                           USANA HEALTH SCIENCES, INC.

             (Exact name of registrant as specified in its charter)

                           Commission File No. 0-21116

                 Utah                                      87-0500306           

    (State or other jurisdiction of             (IRS Employer Identification    

             incorporation)                                 Number)             

                           3838 West Parkway Boulevard
                           Salt Lake City, Utah 84120
               (Address of principal executive offices, Zip Code)

       Registrant's telephone number, including area code: (801) 954-7100

   Former name or former address, if changed since last report: Not Applicable

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
    Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
    Act (17 CFR 240.13e-4(c))

Item 2.02       Results of Operations and Financial Condition

On October 18, 2005, USANA Health Sciences, Inc. issued a press release
announcing its financial results for the third quarter ended October 1, 2005.
The release also announced that executives of the company would discuss these
results with investors on a conference call broadcast over the World Wide Web
and by telephone and provided access information, dates and times for the
conference call. A copy of the press release is furnished herewith as Exhibit 99
to this Current Report on Form 8-K and is incorporated herein by reference. The
company will also post this document on its corporate website,
www.usanahealthsciences.com, under the "investors" link.

The information in this Current Report is being furnished and shall not be
deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of
1934, as amended, or otherwise subject to the liabilities of that Section. The
information in this Current Report shall not be incorporated by reference into
any registration statement or other document pursuant to the Securities Act of
1933, as amended. The furnishing of the information in this Current Report is
not intended to, and does not, constitute a representation that such furnishing
is required by Regulation FD or that the information this Current Report
contains is material investor information that is not otherwise publicly

Item 9.01       Financial Statements and Exhibits (furnished herewith)

                (d) Exhibits

Exhibit 99      Press release issued by USANA Health Sciences, Inc. dated 
                October 18, 2005



     Pursuant to the requirements of the Securities Exchange Act of 1934, the
     registrant has duly caused this report to be signed on its behalf by the
     undersigned hereunto duly authorized.

                                        USANA HEALTH SCIENCES, INC.

                                        By: /s/ Gilbert A. Fuller
                                            Gilbert A. Fuller, Chief Financial 

     Date: October 18, 2005